MX384154B - Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-3 poliinsaturados. - Google Patents

Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-3 poliinsaturados.

Info

Publication number
MX384154B
MX384154B MX2017007846A MX2017007846A MX384154B MX 384154 B MX384154 B MX 384154B MX 2017007846 A MX2017007846 A MX 2017007846A MX 2017007846 A MX2017007846 A MX 2017007846A MX 384154 B MX384154 B MX 384154B
Authority
MX
Mexico
Prior art keywords
composition
polyunsaturated omega
lysine
compositions
stability
Prior art date
Application number
MX2017007846A
Other languages
English (en)
Other versions
MX2017007846A (es
Inventor
Günter Knaup
Michael Schwarm
Milan Latinovic
Original Assignee
Evonik Operations Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52344991&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX384154(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Evonik Operations Gmbh filed Critical Evonik Operations Gmbh
Publication of MX2017007846A publication Critical patent/MX2017007846A/es
Publication of MX384154B publication Critical patent/MX384154B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/02—Other edible oils or fats, e.g. shortenings or cooking oils characterised by the production or working-up
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/186—Fatty acids
    • A23V2250/1882—Polyunsaturated fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Wood Science & Technology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a un proceso para aumentar la estabilidad hacia la oxidación de una composición que comprende ácidos grasos omega-3 poliinsaturados que comprende las siguientes etapas: (i) proporcionar una composición de partida que comprende al menos un componente ácido graso omega-3 poliinsaturado; (ii) proporcionar una composición de lisina; (iii) mezclar soluciones acuosas, acuoso-alcohólicas o alcohólicas de la composición de partida y de la composición de lisina, y someter posteriormente la mezcla resultante a condiciones de secado por pulverización, formando así una composición de producto de lisina con un anión derivado a partir de un ácido graso omega-3 poliinsaturado; presentando la composición del producto un contenido de disolvente SC seleccionado entre los siguientes: SC <5% en peso, SC <3% en peso, SC <1% en peso, SC <0.5% en peso, en donde la composición de partida en la etapa (i) y la composición de lisina en la etapa (ii) se proporcionan de tal manera que al menos el 90% en peso de la composición del producto consiste en una o más sales de cationes derivados de lisina con aniones derivados de uno o más ácidos grasos omega-3 poliinsaturados y otros ácidos grasos naturales.
MX2017007846A 2014-12-23 2015-12-17 Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-3 poliinsaturados. MX384154B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14199989 2014-12-23
PCT/EP2015/080311 WO2016102323A1 (en) 2014-12-23 2015-12-17 Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids

Publications (2)

Publication Number Publication Date
MX2017007846A MX2017007846A (es) 2017-09-19
MX384154B true MX384154B (es) 2025-03-14

Family

ID=52344991

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007846A MX384154B (es) 2014-12-23 2015-12-17 Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-3 poliinsaturados.

Country Status (24)

Country Link
US (2) US10798962B2 (es)
EP (1) EP3236782B1 (es)
JP (1) JP6861156B2 (es)
KR (1) KR102584130B1 (es)
CN (1) CN107105746B (es)
AU (1) AU2015371376B2 (es)
BR (1) BR112017013319B1 (es)
CL (2) CL2017001614A1 (es)
CO (1) CO2017005847A2 (es)
DK (1) DK3236782T3 (es)
ES (1) ES2781863T3 (es)
HU (1) HUE048494T2 (es)
IL (1) IL252481B (es)
MX (1) MX384154B (es)
MY (1) MY179033A (es)
PE (1) PE20171083A1 (es)
PH (1) PH12017501145A1 (es)
PL (1) PL3236782T3 (es)
RU (1) RU2706202C2 (es)
SA (1) SA517381763B1 (es)
SG (1) SG11201704396XA (es)
TW (1) TWI695682B (es)
WO (1) WO2016102323A1 (es)
ZA (1) ZA201704820B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210077446A1 (en) * 2016-12-13 2021-03-18 Dsm Ip Assets B.V. Pufa salt formulations (ii)
CN110267550B (zh) * 2016-12-13 2022-08-30 帝斯曼知识产权资产管理有限公司 多不饱和脂肪酸盐制剂(i)
BR112020003255A2 (pt) * 2017-08-15 2020-08-18 Evonik Operations Gmbh comprimidos com alto teor de ingrediente ativo de sais de aminoácido graxo ômega-3
EP3586642A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Ala enriched polyunsaturated fatty acid compositions
EP3586640A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Dha enriched polyunsaturated fatty acid compositions
US20210393565A1 (en) 2018-11-30 2021-12-23 Evonik Operations Gmbh Preparation for use to increase the formation of one or more specialized pro-resolving lipid mediators (spm)
KR20210097153A (ko) * 2018-11-30 2021-08-06 에보니크 오퍼레이션즈 게엠베하 인지질 및 지방산 염의 분산액을 포함하는 제제
EP3886613A1 (en) 2018-11-30 2021-10-06 Evonik Operations GmbH Preparation comprising a probiotic strain of the genus bacillus megaterium and a polyunsaturated fatty acid component
US20220233487A1 (en) * 2019-05-06 2022-07-28 Evonik Operations Gmbh Preparation for use in weight management comprising omega-3 fatty acid salts and basic amino acids
EP3972430A1 (en) 2019-05-23 2022-03-30 Evonik Operations GmbH Preparation for use in enhancing formation of short-chain fatty acids (scfas)
KR20220041871A (ko) * 2019-08-01 2022-04-01 에보니크 오퍼레이션즈 게엠베하 오메가-3 지방산 염 및 보스웰리아 종으로부터의 검 수지의 추출물을 포함하는 제제
EP4009961A1 (en) 2019-08-08 2022-06-15 Evonik Operations GmbH Solubility enhancement of poorly soluble actives
EP3804699A1 (en) 2019-10-10 2021-04-14 Evonik Operations GmbH Method of preparing a solid dosage form and a binder
MX2022001570A (es) 2019-08-08 2022-03-02 Evonik Operations Gmbh Proceso de flujo descendente para la produccion de sales de acidos grasos poliinsaturados.
MX2022001568A (es) 2019-08-08 2022-03-02 Evonik Operations Gmbh Procedimiento de preparacion de una forma de dosificacion solida y un lubricante.
WO2021023850A1 (en) 2019-08-08 2021-02-11 Evonik Operations Gmbh Method of preparing a solid dosage form and a binder
JP2023514506A (ja) * 2020-01-30 2023-04-06 シリサイクル インコーポレイティド 多価不飽和脂肪酸の固体中性アミノ酸塩の製造プロセス
CA3168635A1 (en) * 2020-01-30 2021-08-05 Silicycle Inc. Process for preparing a solid form of basic amino acid salts of polyunsaturated fatty acids
WO2021197971A1 (en) 2020-04-01 2021-10-07 Evonik Operations Gmbh Preparation for use as antioxidant
US20230037453A1 (en) 2020-04-01 2023-02-09 Evonik Operations Gmbh Preparation for use as vasorelaxant

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2945049A (en) 1959-05-25 1960-07-12 Gen Mills Inc Salts of basic amino acids and linoleic acid
HU199775B (en) * 1988-03-09 1990-03-28 Nagy Peter Literati Process for production of formed by fatty acids salts of amin acids and medical compositions containing them
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
KR960013387A (ko) * 1994-10-13 1996-05-22 오동빈 Dha과립분말 및 그의 제조방법
CN1463745A (zh) * 2002-06-14 2003-12-31 丁强 一种全元营养素补充剂
EP2573188A2 (en) * 2005-03-02 2013-03-27 Metanomics GmbH Process for the production of fine chemicals
US7867538B2 (en) * 2005-12-20 2011-01-11 Archer Daniels Midland Company Processes of improving the quality of oil and products produced therefrom
US9056058B2 (en) * 2006-06-05 2015-06-16 Dsm Nutritional Products Microcapsules with improved shells
WO2008003064A2 (en) * 2006-06-29 2008-01-03 Martek Biosciences Corporation Sweetened oil compositions and methods of making
RU2611808C2 (ru) * 2007-11-01 2017-03-01 Энзимотек Лтд. Липидная смесь для детского питания
DK2366766T3 (en) * 2010-03-09 2017-03-27 Stepan Specialty Products Llc Process for treating an edible oil and thus obtained oil
US8609138B2 (en) 2010-06-30 2013-12-17 Mochida Pharmaceutical Co., Ltd. ω3 fatty acid compound preparation
WO2014011895A2 (en) * 2012-07-11 2014-01-16 Thetis Pharmaceuticals Llc High solubility acid salts, intravenous dosage forms, nutrition supplementation and methods of use thereof

Also Published As

Publication number Publication date
NZ732378A (en) 2024-07-05
MX2017007846A (es) 2017-09-19
KR102584130B1 (ko) 2023-10-04
RU2017125962A3 (es) 2019-06-18
CA2969159A1 (en) 2016-06-30
MY179033A (en) 2020-10-26
PH12017501145A1 (en) 2018-03-05
US20170360072A1 (en) 2017-12-21
HUE048494T2 (hu) 2020-07-28
IL252481A0 (en) 2017-07-31
BR112017013319B1 (pt) 2021-11-30
US10798962B2 (en) 2020-10-13
IL252481B (en) 2021-08-31
SG11201704396XA (en) 2017-07-28
JP2018502085A (ja) 2018-01-25
CL2017001614A1 (es) 2018-01-12
RU2706202C2 (ru) 2019-11-15
EP3236782B1 (en) 2020-02-05
US11805798B2 (en) 2023-11-07
SA517381763B1 (ar) 2021-06-06
CL2020000141A1 (es) 2020-06-05
PL3236782T3 (pl) 2020-06-29
KR20170094788A (ko) 2017-08-21
CN107105746A (zh) 2017-08-29
CN107105746B (zh) 2020-11-10
RU2017125962A (ru) 2019-01-24
BR112017013319A2 (pt) 2018-04-10
TWI695682B (zh) 2020-06-11
WO2016102323A1 (en) 2016-06-30
ES2781863T3 (es) 2020-09-08
AU2015371376A1 (en) 2017-06-22
JP6861156B2 (ja) 2021-04-21
ZA201704820B (en) 2019-06-26
DK3236782T3 (da) 2020-04-27
PE20171083A1 (es) 2017-08-03
TW201639464A (zh) 2016-11-16
AU2015371376B2 (en) 2020-04-23
CO2017005847A2 (es) 2017-08-31
US20200375235A1 (en) 2020-12-03
EP3236782A1 (en) 2017-11-01

Similar Documents

Publication Publication Date Title
MX384154B (es) Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-3 poliinsaturados.
MX391057B (es) Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-6 poliinsaturados.
BR112018074009A2 (pt) método para preparar uma composição compreendendo sais de ácidos graxos ômega-3
MX2017012270A (es) Composiciones sinergicas de acido dehidroacetico y metodos para reducir el amarillamiento en varias composiciones de usuario final.
MY190760A (en) Method of manufacturing a frozen confection with low sfa coating and product obtained
NZ747847A (en) Lipid compositions
EA202090592A1 (ru) Композиция, содержащая растительное масло, источник органических кислот, фенольные соединения и аминокислоты
WO2017171423A3 (ko) 갈릭산 함량이 증진된 연 캘러스 추출물, 이의 제조방법 및 이를 함유하는 미백용 화장료 조성물
EA201890018A1 (ru) Композиция для придания формы волосам
AU2017251090A1 (en) Methods of manufacturing nutritional formulations
BR112015020514A2 (pt) composições de proteína solúvel em álcool aquosas à base de água, aplicações e métodos
WO2015013678A3 (en) Stable fatty acid compositions
EA033545B1 (ru) Композиции для нанесения покрытий на основе шеллака и эмульгатора и способы нанесения покрытия на продукт питания
NZ732380B2 (en) Process for increasing the stability of a composition comprising polyunsaturated omega-6 fatty acids
PE20221451A1 (es) Producto alimenticio en polvo, semi terminado, basado en alimentos vegetales y un proceso para la produccion del mismo
NZ732378B2 (en) Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids
WO2016023833A3 (en) Process for production of branched alcohols, and fuel composition containing them
EA201691518A1 (ru) Композиции, содержащие продукты пчеловодства
Alexandrova Formulating sustainable garden putty for fruit and ornamental trees based on pine oleoresin
TH2001002792A (th) วิธีการสำหรับการผลิตองค์ประกอบกรดเปอร์อะซิติกที่จะถูกใช้ดังสารเติมอาหาร
PH12018500790A1 (en) Coffee cream oil composition
HK1252707A1 (zh) 鱼油的冬化
MX2019000127A (es) Compuestos de 6-isopropil-2,4-dimetilciclohexen-1-ol como ingredientes de fragancias.
MX2018012342A (es) Procedimiento de preparacion de un producto de hidrato de monoglicerido.
TH168092A (th) องค์ประกอบเครื่องสำอางที่ประกอบด้วยน้ำส้มสายชูมินท์ดังส่วนประกอบออกฤทธิ์